Video: Jim Cramer on the Eagles, Celgene, Juno Therapeutics and Netflix

TheStreet's founder and Action Alerts PLUS Portfolio Manager Jim Cramer reacts to Monday's trending topics.
Author:
Publish date:

TheStreet's founder and Action Alerts PLUS Portfolio Manager Jim Cramer reacts to Monday's trending topics including the Philadelphia Eagle's Sunday victory, Celgene's (CELG) - Get Report plans to buy Juno Therapeutics (JUNO) and what to expect from Netflix's (NFLX) - Get Report upcoming quarterly earnings. 

Want more exclusive investing insight from Jim Cramer? Get 24/7 access to Jim's charitable trust portfolio with a free trial to Action Alerts PLUS!

Watch all of Jim Cramer's full NYSE live shows right here: